May 26, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Atara Biotherapeutics, Inc. (“Atara” or “the Company”) (NASDAQ: ATRA). Investors who purchased Atara securities prior to May 20, 2024, and continue to hold to the present, are encouraged to obtain additional… read more
May 26, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Rumble Inc. (“Rumble” or “the Company”) (NASDAQ: RUM). Investors who purchased Rumble securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Rumble has violated federal… read more
May 26, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of UP Fintech Holding Limited (“UP Fintech” or “the Company”) (NASDAQ: TIGR). Investors who purchased UP Fintech securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
May 26, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sleep Number Corporation (“Sleep Number” or “the Company”) (NASDAQ: SNBR). Investors who purchased Sleep Number securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Sleep… read more
May 21, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Doximity, Inc. (“Doximity” or “the Company”) (NYSE: DOCS). Investors who purchased Doximity securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Doximity has violated federal… read more
May 21, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sigma Lithium Corporation (“Sigma” or “the Company”) (NASDAQ: SGML). Investors who purchased Sigma securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Sigma has violated… read more
May 20, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Power Solutions International, Inc. (“Power Solutions” or “the Company”) (NASDAQ: PSIX). Investors who purchased Power Solutions securities prior to May 8, 2025, and continue to hold to the present, are encouraged… read more
May 20, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Gartner, Inc. (“Gartner” or “the Company”) (NYSE: IT). Investors who purchased Gartner securities prior to February 4, 2026, and continue to hold to the present, are encouraged to obtain additional information… read more
May 20, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Aquestive Therapeutics, Inc. (“Aquestive” or “the Company”) (NASDAQ: AQST). Investors who purchased Aquestive securities prior to June 16, 2025, and continue to hold to the present, are encouraged to obtain additional… read more
May 20, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Nektar Therapeutics (“Nektar” or “the Company”) (NASDAQ: NKTR). Investors who purchased Nektar securities prior to February 26, 2025, and continue to hold to the present, are encouraged to obtain additional information… read more
May 20, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Eos Energy Enterprises, Inc. (“Eos Energy” or “the Company”) (NASDAQ: EOSE). Investors who purchased Eos Energy securities prior to November 5, 2025, and continue to hold to the present, are encouraged… read more
May 20, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Soleno Therapeutics, Inc. (“Soleno” or “the Company”) (NASDAQ: SLNO). Investors who purchased Soleno securities prior to May 26, 2025, and continue to hold to the present, are encouraged to obtain additional… read more
May 20, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Apollo Global Management, Inc. (“Apollo” or “the Company”) (NYSE: APO). Investors who purchased Apollo securities prior to May 10, 2021, and continue to hold to the present, are encouraged to obtain… read more
May 20, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of TriSalus Life Sciences, Inc. (“TriSalus” or “the Company”) (NASDAQ: TLSI). Investors who purchased TriSalus securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether TriSalus has… read more
May 20, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Arm Holdings plc (“Arm Holdings plc” or “the Company”) (NASDAQ: ARM). Investors who purchased Arm Holdings plc securities are encouraged to obtain additional information and assist the investigation. The investigation concerns… read more
May 20, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Armstrong World Industries, Inc. (“Armstrong” or “the Company”) (NYSE: AWI). Investors who purchased Armstrong securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Armstrong has… read more
May 20, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Prestige Consumer Healthcare Inc. (“Prestige” or “the Company”) (NYSE: PBH). Investors who purchased Prestige securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Prestige has… read more
May 20, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Certara, Inc. (“Certara” or “the Company”) (NASDAQ: CERT). Investors who purchased Certara securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Certara has violated federal… read more
May 20, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Upwork Inc. (“Upwork” or “the Company”) (NASDAQ: UPWK). Investors who purchased Upwork securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Upwork has violated federal… read more
May 20, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Dominion Energy, Inc. (“Dominion Energy”) (NYSE: D) and NextEra Energy, Inc. (“NextEra”) (NYSE: NEE). Investors who purchased Dominion Energy and continue to hold to the present are encouraged to obtain additional information and assist the… read more
May 19, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of York Space Systems, Inc. (“York” or “the Company”) (NYSE: YSS). Investors who purchased York securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether York has… read more
May 18, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Alphatec Holdings, Inc. (“Alphatec” or “the Company”) (NASDAQ: ATEC). Investors who purchased Alphatec securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Alphatec has violated… read more
May 18, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Claritev Corporation (“Claritev” or “the Company”) (NYSE: CTEV). Investors who purchased Claritev securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Claritev has violated federal… read more
May 15, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Azenta, Inc. (“Azenta” or “the Company”) (NASDAQ: AZTA). Investors who purchased Azenta securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Azenta has violated federal… read more
May 15, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Ashland Inc. (“Ashland” or “the Company”) (NYSE: ASH). Investors who purchased Ashland securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Ashland has violated federal… read more
May 15, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Amplitude, Inc. (“Amplitude” or “the Company”) (NASDAQ: AMPL). Investors who purchased Amplitude securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Amplitude has violated federal… read more
May 12, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Entrada Therapeutics, Inc. (“Entrada” or “the Company”) (NASDAQ: TRDA). Investors who purchased Entrada securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Entrada has violated… read more
May 12, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cencora, Inc. (“Cencora” or “the Company”) (NYSE: COR). Investors who purchased Cencora securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Cencora has violated federal… read more
May 12, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Whirlpool Corporation (“Whirlpool” or “the Company”) (NYSE: WHR). Investors who purchased Whirlpool securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Whirlpool has violated federal… read more
May 12, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Shake Shack, Inc. (“Shake Shack” or “the Company”) (NYSE: SHAK). Investors who purchased Shake Shack securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Shake… read more